Literature DB >> 30316862

Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol rottlerin.

Katarina Siposova1, Tibor Kozar2, Veronika Huntosova2, Silvia Tomkova3, Andrey Musatov4.   

Abstract

Natural polyphenols, curcumin, rottlerin and EGCG were selected for initial computational modeling of protein-ligand interaction patterns. The docking calculations demonstrated that these polyphenols can easily adjust their conformational shape to fit well into the binding sites of amyloidogenic proteins. The experimental part of the study focused on the effect of rottlerin on fibrillation of three distinct amyloidogenic proteins, namely insulin, lysozyme and Aβ1-40 peptide. Different experimental protocols such as fluorescence spectroscopy, circular dichroism and atomic force microscopy, demonstrated that amyloid fibril formation of any of the three proteins is inhibited by low micromolar rottlerin concentrations. Most likely, the inhibition of amyloid formation proceeded via interaction of rottlerin with amyloidogenic regions of the studied proteins. Moreover, rottlerin was also effective in pre-formed fibrils disassembly, suggesting that interactions of rottlerin with fibrils were capable to interrupt the fibril-stabilizing bonds of β-sheets. The apparent IC50 and DC50 values were calculated in the range of 1.3-36.4 μM and 15.6-25.8 μM, respectively. The strongest inhibiting/disassembling effect of rottlerin was observed on Aβ1-40 peptide. The cytotoxicity assay performed on the Neuro 2a cells indicated time-dependent cell morphology changes but rottlerin affected the cell viability only at concentration above 50 μM. The results of this study suggest that chemical modifications on rottlerin could be tested in the future as a promising strategy for the modulation of amyloidogenic proteins aggregation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid aggregation; Aβ peptide; Insulin; Lysozyme; Polyphenols; Rottlerin

Mesh:

Substances:

Year:  2018        PMID: 30316862     DOI: 10.1016/j.bbapap.2018.10.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  5 in total

1.  Dual-Functional Antioxidant and Antiamyloid Cerium Oxide Nanoparticles Fabricated by Controlled Synthesis in Water-Alcohol Solutions.

Authors:  Katarina Siposova; Veronika Huntosova; Ivana Garcarova; Yuliia Shlapa; Illia Timashkov; Anatolii Belous; Andrey Musatov
Journal:  Biomedicines       Date:  2022-04-19

Review 2.  Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands.

Authors:  Laura Blaikie; Graeme Kay; Paul Kong Thoo Lin
Journal:  Medchemcomm       Date:  2019-10-16       Impact factor: 3.597

3.  Nanomedical Relevance of the Intermolecular Interaction Dynamics-Examples from Lysozymes and Insulins.

Authors:  Ruiyan Zhang; Ning Zhang; Marzieh Mohri; Lisha Wu; Thomas Eckert; Vadim B Krylov; Andrea Antosova; Slavomira Ponikova; Zuzana Bednarikova; Philipp Markart; Andreas Günther; Bengt Norden; Martin Billeter; Roland Schauer; Axel J Scheidig; Bhisma N Ratha; Anirban Bhunia; Karsten Hesse; Mushira Abdelaziz Enani; Jürgen Steinmeyer; Athanasios K Petridis; Tibor Kozar; Zuzana Gazova; Nikolay E Nifantiev; Hans-Christian Siebert
Journal:  ACS Omega       Date:  2019-02-27

4.  The intriguing dose-dependent effect of selected amphiphilic compounds on insulin amyloid aggregation: Focus on a cholesterol-based detergent, Chobimalt.

Authors:  Katarina Siposova; Viktor I Petrenko; Ivana Garcarova; Dagmar Sedlakova; László Almásy; Olena A Kyzyma; Manfred Kriechbaum; Andrey Musatov
Journal:  Front Mol Biosci       Date:  2022-08-19

5.  Spearmint Extract Containing Rosmarinic Acid Suppresses Amyloid Fibril Formation of Proteins Associated with Dementia.

Authors:  Kenjirou Ogawa; Ayumi Ishii; Aimi Shindo; Kunihiro Hongo; Tomohiro Mizobata; Tetsuya Sogon; Yasushi Kawata
Journal:  Nutrients       Date:  2020-11-13       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.